nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—L-DOPA—Mesalazine—Crohn's disease	0.729	1	CrCrCtD
Melphalan—Venoocclusive disease—Azathioprine—Crohn's disease	0.012	0.068	CcSEcCtD
Melphalan—SLC22A3—Organic cation transport—SLC22A5—Crohn's disease	0.0106	0.18	CbGpPWpGaD
Melphalan—SLC22A3—Organic cation transport—SLC22A4—Crohn's disease	0.0106	0.18	CbGpPWpGaD
Melphalan—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00716	0.122	CbGpPWpGaD
Melphalan—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00716	0.122	CbGpPWpGaD
Melphalan—SLC7A5—Balsalazide—Sulfasalazine—Crohn's disease	0.00584	0.878	CbGdCrCtD
Melphalan—Myelosuppression—Mercaptopurine—Crohn's disease	0.00496	0.028	CcSEcCtD
Melphalan—Acute leukaemia—Azathioprine—Crohn's disease	0.00485	0.0274	CcSEcCtD
Melphalan—Infertility—Mesalazine—Crohn's disease	0.00484	0.0273	CcSEcCtD
Melphalan—Wound—Prednisone—Crohn's disease	0.0046	0.026	CcSEcCtD
Melphalan—Non-Hodgkin's lymphoma—Azathioprine—Crohn's disease	0.00397	0.0224	CcSEcCtD
Melphalan—Lymphoma—Azathioprine—Crohn's disease	0.00397	0.0224	CcSEcCtD
Melphalan—Skin necrosis—Mesalazine—Crohn's disease	0.00361	0.0204	CcSEcCtD
Melphalan—Bone marrow depression—Mercaptopurine—Crohn's disease	0.00345	0.0195	CcSEcCtD
Melphalan—SLC22A3—mouth—Crohn's disease	0.00344	0.13	CbGeAlD
Melphalan—SLC7A5—epithelium—Crohn's disease	0.00323	0.122	CbGeAlD
Melphalan—SLC7A5—smooth muscle tissue—Crohn's disease	0.00311	0.117	CbGeAlD
Melphalan—SLC7A5—skin of body—Crohn's disease	0.00307	0.116	CbGeAlD
Melphalan—Myelosuppression—Azathioprine—Crohn's disease	0.00296	0.0167	CcSEcCtD
Melphalan—Interstitial pneumonia—Azathioprine—Crohn's disease	0.00287	0.0162	CcSEcCtD
Melphalan—Muscle atrophy—Prednisone—Crohn's disease	0.00283	0.016	CcSEcCtD
Melphalan—SLC7A5—mammalian vulva—Crohn's disease	0.0028	0.106	CbGeAlD
Melphalan—Interstitial pneumonia—Mesalazine—Crohn's disease	0.00261	0.0148	CcSEcCtD
Melphalan—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.00251	0.0142	CcSEcCtD
Melphalan—SLC7A5—lymphoid tissue—Crohn's disease	0.00248	0.0937	CbGeAlD
Melphalan—Ulcer—Mercaptopurine—Crohn's disease	0.00246	0.0139	CcSEcCtD
Melphalan—SLC7A5—digestive system—Crohn's disease	0.00245	0.0926	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.00243	0.0414	CbGpPWpGaD
Melphalan—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.00237	0.0134	CcSEcCtD
Melphalan—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.00233	0.0131	CcSEcCtD
Melphalan—Local reaction—Mesalazine—Crohn's disease	0.00228	0.0129	CcSEcCtD
Melphalan—Foetor hepaticus—Mesalazine—Crohn's disease	0.00222	0.0126	CcSEcCtD
Melphalan—Neoplasm—Mercaptopurine—Crohn's disease	0.0021	0.0119	CcSEcCtD
Melphalan—Mouth ulceration—Mercaptopurine—Crohn's disease	0.0021	0.0119	CcSEcCtD
Melphalan—Transaminases increased—Mesalazine—Crohn's disease	0.00207	0.0117	CcSEcCtD
Melphalan—Bone marrow depression—Azathioprine—Crohn's disease	0.00205	0.0116	CcSEcCtD
Melphalan—Interstitial lung disease—Azathioprine—Crohn's disease	0.00196	0.0111	CcSEcCtD
Melphalan—SLC22A3—smooth muscle tissue—Crohn's disease	0.00193	0.0728	CbGeAlD
Melphalan—Bone marrow depression—Mesalazine—Crohn's disease	0.00187	0.0106	CcSEcCtD
Melphalan—Liver disorder—Mesalazine—Crohn's disease	0.00185	0.0105	CcSEcCtD
Melphalan—Interstitial lung disease—Mesalazine—Crohn's disease	0.00178	0.0101	CcSEcCtD
Melphalan—SLC22A3—mammalian vulva—Crohn's disease	0.00174	0.0655	CbGeAlD
Melphalan—Dermatitis atopic—Mesalazine—Crohn's disease	0.00171	0.00964	CcSEcCtD
Melphalan—Neoplasm malignant—Azathioprine—Crohn's disease	0.00162	0.00917	CcSEcCtD
Melphalan—Feeling hot—Mesalazine—Crohn's disease	0.00161	0.00909	CcSEcCtD
Melphalan—Impaired healing—Prednisone—Crohn's disease	0.00154	0.00873	CcSEcCtD
Melphalan—Amenorrhoea—Mesalazine—Crohn's disease	0.00144	0.00812	CcSEcCtD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00143	0.0244	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00143	0.0244	CbGpPWpGaD
Melphalan—Vasculitis—Azathioprine—Crohn's disease	0.00142	0.00803	CcSEcCtD
Melphalan—SLC7A5—lymph node—Crohn's disease	0.0014	0.0529	CbGeAlD
Melphalan—Hepatocellular injury—Azathioprine—Crohn's disease	0.00139	0.00783	CcSEcCtD
Melphalan—Pancytopenia—Mercaptopurine—Crohn's disease	0.00139	0.00783	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00128	0.0218	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00128	0.0218	CbGpPWpGaD
Melphalan—Stomatitis—Mercaptopurine—Crohn's disease	0.00127	0.00717	CcSEcCtD
Melphalan—Hepatocellular injury—Mesalazine—Crohn's disease	0.00126	0.00714	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ITGA4—Crohn's disease	0.00126	0.0214	CbGpPWpGaD
Melphalan—Neoplasm—Azathioprine—Crohn's disease	0.00125	0.00708	CcSEcCtD
Melphalan—Cystitis noninfective—Mesalazine—Crohn's disease	0.00123	0.00697	CcSEcCtD
Melphalan—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00123	0.00696	CcSEcCtD
Melphalan—Cystitis—Mesalazine—Crohn's disease	0.00122	0.00689	CcSEcCtD
Melphalan—Skin exfoliation—Mesalazine—Crohn's disease	0.00121	0.00681	CcSEcCtD
Melphalan—Neuropathy—Mesalazine—Crohn's disease	0.00119	0.0067	CcSEcCtD
Melphalan—Ibuprofen—CXCL8—Crohn's disease	0.00116	0.645	CrCbGaD
Melphalan—Bladder pain—Mesalazine—Crohn's disease	0.00114	0.00645	CcSEcCtD
Melphalan—Mouth ulceration—Mesalazine—Crohn's disease	0.00114	0.00645	CcSEcCtD
Melphalan—Febrile neutropenia—Prednisone—Crohn's disease	0.00111	0.00628	CcSEcCtD
Melphalan—Immune system disorder—Mercaptopurine—Crohn's disease	0.00105	0.00596	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.00105	0.0178	CbGpPWpGaD
Melphalan—Alopecia—Mercaptopurine—Crohn's disease	0.00103	0.00583	CcSEcCtD
Melphalan—Renal failure acute—Mesalazine—Crohn's disease	0.000993	0.00561	CcSEcCtD
Melphalan—Atrial fibrillation—Mesalazine—Crohn's disease	0.000967	0.00547	CcSEcCtD
Melphalan—Anaemia—Mercaptopurine—Crohn's disease	0.00094	0.00531	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000933	0.0159	CbGpPWpGaD
Melphalan—Leukopenia—Mercaptopurine—Crohn's disease	0.00091	0.00515	CcSEcCtD
Melphalan—Dermatitis atopic—Prednisone—Crohn's disease	0.000902	0.0051	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000901	0.0153	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000893	0.0152	CbGpPWpGaD
Melphalan—SLC22A3—lymph node—Crohn's disease	0.00087	0.0328	CbGeAlD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00086	0.00486	CcSEcCtD
Melphalan—Liver function test abnormal—Mesalazine—Crohn's disease	0.000846	0.00478	CcSEcCtD
Melphalan—Oedema—Mercaptopurine—Crohn's disease	0.00083	0.00469	CcSEcCtD
Melphalan—Pancytopenia—Azathioprine—Crohn's disease	0.000826	0.00467	CcSEcCtD
Melphalan—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000812	0.00459	CcSEcCtD
Melphalan—SLC7A5—Desoximetasone—Prednisone—Crohn's disease	0.000811	0.122	CbGdCrCtD
Melphalan—Skin disorder—Mercaptopurine—Crohn's disease	0.000806	0.00456	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000797	0.0136	CbGpPWpGaD
Melphalan—Anorexia—Mercaptopurine—Crohn's disease	0.000791	0.00447	CcSEcCtD
Melphalan—Bronchospasm—Mesalazine—Crohn's disease	0.000779	0.0044	CcSEcCtD
Melphalan—Amenorrhoea—Prednisone—Crohn's disease	0.00076	0.0043	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000756	0.00427	CcSEcCtD
Melphalan—Pancytopenia—Mesalazine—Crohn's disease	0.000752	0.00425	CcSEcCtD
Melphalan—Neutropenia—Mesalazine—Crohn's disease	0.000741	0.00419	CcSEcCtD
Melphalan—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000733	0.00414	CcSEcCtD
Melphalan—Decreased appetite—Mercaptopurine—Crohn's disease	0.000721	0.00408	CcSEcCtD
Melphalan—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000716	0.00405	CcSEcCtD
Melphalan—Ulcer—Prednisone—Crohn's disease	0.000706	0.00399	CcSEcCtD
Melphalan—Haemoglobin—Azathioprine—Crohn's disease	0.000699	0.00395	CcSEcCtD
Melphalan—Haemorrhage—Azathioprine—Crohn's disease	0.000696	0.00393	CcSEcCtD
Melphalan—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000692	0.00391	CcSEcCtD
Melphalan—Stomatitis—Mesalazine—Crohn's disease	0.000688	0.00389	CcSEcCtD
Melphalan—Jaundice—Mesalazine—Crohn's disease	0.000688	0.00389	CcSEcCtD
Melphalan—Vasculitis—Prednisone—Crohn's disease	0.000684	0.00387	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000677	0.0115	CbGpPWpGaD
Melphalan—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000668	0.00378	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000652	0.0111	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000652	0.0111	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00065	0.0111	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00065	0.0111	CbGpPWpGaD
Melphalan—Skin exfoliation—Prednisone—Crohn's disease	0.000638	0.0036	CcSEcCtD
Melphalan—Haemoglobin—Mesalazine—Crohn's disease	0.000637	0.0036	CcSEcCtD
Melphalan—Hepatitis—Mesalazine—Crohn's disease	0.000634	0.00358	CcSEcCtD
Melphalan—Haemorrhage—Mesalazine—Crohn's disease	0.000634	0.00358	CcSEcCtD
Melphalan—Immune system disorder—Azathioprine—Crohn's disease	0.000629	0.00355	CcSEcCtD
Melphalan—Mediastinal disorder—Azathioprine—Crohn's disease	0.000627	0.00355	CcSEcCtD
Melphalan—Neuropathy—Prednisone—Crohn's disease	0.000627	0.00354	CcSEcCtD
Melphalan—Urinary tract disorder—Mesalazine—Crohn's disease	0.000626	0.00354	CcSEcCtD
Melphalan—Connective tissue disorder—Mesalazine—Crohn's disease	0.000623	0.00352	CcSEcCtD
Melphalan—Arrhythmia—Azathioprine—Crohn's disease	0.000622	0.00351	CcSEcCtD
Melphalan—Urethral disorder—Mesalazine—Crohn's disease	0.000621	0.00351	CcSEcCtD
Melphalan—Alopecia—Azathioprine—Crohn's disease	0.000615	0.00348	CcSEcCtD
Melphalan—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000611	0.00346	CcSEcCtD
Melphalan—Immune system disorder—Mesalazine—Crohn's disease	0.000573	0.00324	CcSEcCtD
Melphalan—Mediastinal disorder—Mesalazine—Crohn's disease	0.000571	0.00323	CcSEcCtD
Melphalan—Diarrhoea—Mercaptopurine—Crohn's disease	0.000568	0.00321	CcSEcCtD
Melphalan—Alopecia—Mesalazine—Crohn's disease	0.00056	0.00317	CcSEcCtD
Melphalan—Anaemia—Azathioprine—Crohn's disease	0.00056	0.00317	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—F5—Crohn's disease	0.000555	0.00944	CbGpPWpGaD
Melphalan—Leukopenia—Azathioprine—Crohn's disease	0.000542	0.00307	CcSEcCtD
Melphalan—Vomiting—Mercaptopurine—Crohn's disease	0.000528	0.00298	CcSEcCtD
Melphalan—Rash—Mercaptopurine—Crohn's disease	0.000523	0.00296	CcSEcCtD
Melphalan—Dermatitis—Mercaptopurine—Crohn's disease	0.000523	0.00296	CcSEcCtD
Melphalan—Myalgia—Azathioprine—Crohn's disease	0.000516	0.00292	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000512	0.0029	CcSEcCtD
Melphalan—Anaemia—Mesalazine—Crohn's disease	0.00051	0.00288	CcSEcCtD
Melphalan—Leukopenia—Mesalazine—Crohn's disease	0.000494	0.00279	CcSEcCtD
Melphalan—Nausea—Mercaptopurine—Crohn's disease	0.000493	0.00279	CcSEcCtD
Melphalan—Infection—Azathioprine—Crohn's disease	0.000491	0.00278	CcSEcCtD
Melphalan—Thrombocytopenia—Azathioprine—Crohn's disease	0.000484	0.00274	CcSEcCtD
Melphalan—Cough—Mesalazine—Crohn's disease	0.000482	0.00272	CcSEcCtD
Melphalan—Skin disorder—Azathioprine—Crohn's disease	0.00048	0.00272	CcSEcCtD
Melphalan—Chest pain—Mesalazine—Crohn's disease	0.00047	0.00266	CcSEcCtD
Melphalan—Myalgia—Mesalazine—Crohn's disease	0.00047	0.00266	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000467	0.00264	CcSEcCtD
Melphalan—Hypotension—Azathioprine—Crohn's disease	0.000462	0.00261	CcSEcCtD
Melphalan—Cardiac arrest—Prednisone—Crohn's disease	0.000461	0.00261	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000459	0.00782	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000458	0.0078	CbGpPWpGaD
Melphalan—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00045	0.00255	CcSEcCtD
Melphalan—Anaphylactic shock—Mesalazine—Crohn's disease	0.00045	0.00255	CcSEcCtD
Melphalan—Oedema—Mesalazine—Crohn's disease	0.00045	0.00255	CcSEcCtD
Melphalan—Infection—Mesalazine—Crohn's disease	0.000447	0.00253	CcSEcCtD
Melphalan—Thrombocytopenia—Mesalazine—Crohn's disease	0.000441	0.00249	CcSEcCtD
Melphalan—Tachycardia—Mesalazine—Crohn's disease	0.00044	0.00248	CcSEcCtD
Melphalan—Skin disorder—Mesalazine—Crohn's disease	0.000437	0.00247	CcSEcCtD
Melphalan—Anorexia—Mesalazine—Crohn's disease	0.000429	0.00243	CcSEcCtD
Melphalan—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000427	0.00241	CcSEcCtD
Melphalan—Hypotension—Mesalazine—Crohn's disease	0.000421	0.00238	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00041	0.00232	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000406	0.00691	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000405	0.00689	CbGpPWpGaD
Melphalan—Paraesthesia—Mesalazine—Crohn's disease	0.000404	0.00229	CcSEcCtD
Melphalan—Dyspnoea—Mesalazine—Crohn's disease	0.000402	0.00227	CcSEcCtD
Melphalan—Dyspepsia—Mesalazine—Crohn's disease	0.000396	0.00224	CcSEcCtD
Melphalan—Neutropenia—Prednisone—Crohn's disease	0.000392	0.00222	CcSEcCtD
Melphalan—Decreased appetite—Mesalazine—Crohn's disease	0.000392	0.00221	CcSEcCtD
Melphalan—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000389	0.0022	CcSEcCtD
Melphalan—Fatigue—Mesalazine—Crohn's disease	0.000388	0.0022	CcSEcCtD
Melphalan—Pain—Mesalazine—Crohn's disease	0.000385	0.00218	CcSEcCtD
Melphalan—Neuropathy peripheral—Prednisone—Crohn's disease	0.000366	0.00207	CcSEcCtD
Melphalan—Hypersensitivity—Azathioprine—Crohn's disease	0.000364	0.00206	CcSEcCtD
Melphalan—Urticaria—Mesalazine—Crohn's disease	0.000358	0.00202	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ITGA4—Crohn's disease	0.000341	0.00581	CbGpPWpGaD
Melphalan—Diarrhoea—Azathioprine—Crohn's disease	0.000338	0.00191	CcSEcCtD
Melphalan—Ibuprofen—PTGS2—Crohn's disease	0.000338	0.188	CrCbGaD
Melphalan—Haemoglobin—Prednisone—Crohn's disease	0.000337	0.00191	CcSEcCtD
Melphalan—Haemorrhage—Prednisone—Crohn's disease	0.000335	0.0019	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—IL3—Crohn's disease	0.000332	0.00566	CbGpPWpGaD
Melphalan—Hypersensitivity—Mesalazine—Crohn's disease	0.000332	0.00188	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000331	0.00564	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000331	0.00564	CbGpPWpGaD
Melphalan—Connective tissue disorder—Prednisone—Crohn's disease	0.00033	0.00186	CcSEcCtD
Melphalan—Asthenia—Mesalazine—Crohn's disease	0.000323	0.00183	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—RASGRP1—Crohn's disease	0.000322	0.00548	CbGpPWpGaD
Melphalan—Pruritus—Mesalazine—Crohn's disease	0.000319	0.0018	CcSEcCtD
Melphalan—Vomiting—Azathioprine—Crohn's disease	0.000314	0.00178	CcSEcCtD
Melphalan—Rash—Azathioprine—Crohn's disease	0.000312	0.00176	CcSEcCtD
Melphalan—Dermatitis—Azathioprine—Crohn's disease	0.000311	0.00176	CcSEcCtD
Melphalan—Flushing—Prednisone—Crohn's disease	0.000311	0.00176	CcSEcCtD
Melphalan—Diarrhoea—Mesalazine—Crohn's disease	0.000308	0.00174	CcSEcCtD
Melphalan—Immune system disorder—Prednisone—Crohn's disease	0.000303	0.00171	CcSEcCtD
Melphalan—Ibuprofen—ALB—Crohn's disease	0.000301	0.168	CrCbGaD
Melphalan—Arrhythmia—Prednisone—Crohn's disease	0.0003	0.00169	CcSEcCtD
Melphalan—Alopecia—Prednisone—Crohn's disease	0.000296	0.00168	CcSEcCtD
Melphalan—Nausea—Azathioprine—Crohn's disease	0.000294	0.00166	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000287	0.00488	CbGpPWpGaD
Melphalan—Vomiting—Mesalazine—Crohn's disease	0.000286	0.00162	CcSEcCtD
Melphalan—Rash—Mesalazine—Crohn's disease	0.000284	0.00161	CcSEcCtD
Melphalan—Dermatitis—Mesalazine—Crohn's disease	0.000284	0.0016	CcSEcCtD
Melphalan—Anaemia—Prednisone—Crohn's disease	0.00027	0.00153	CcSEcCtD
Melphalan—Nausea—Mesalazine—Crohn's disease	0.000268	0.00151	CcSEcCtD
Melphalan—Convulsion—Prednisone—Crohn's disease	0.000253	0.00143	CcSEcCtD
Melphalan—Myalgia—Prednisone—Crohn's disease	0.000249	0.00141	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000247	0.0014	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisone—Crohn's disease	0.000238	0.00135	CcSEcCtD
Melphalan—Oedema—Prednisone—Crohn's disease	0.000238	0.00135	CcSEcCtD
Melphalan—Infection—Prednisone—Crohn's disease	0.000237	0.00134	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000233	0.00397	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IL2RA—Crohn's disease	0.000233	0.00397	CbGpPWpGaD
Melphalan—Tachycardia—Prednisone—Crohn's disease	0.000233	0.00131	CcSEcCtD
Melphalan—Skin disorder—Prednisone—Crohn's disease	0.000231	0.00131	CcSEcCtD
Melphalan—Anorexia—Prednisone—Crohn's disease	0.000227	0.00128	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000217	0.00123	CcSEcCtD
Melphalan—Paraesthesia—Prednisone—Crohn's disease	0.000214	0.00121	CcSEcCtD
Melphalan—Dyspepsia—Prednisone—Crohn's disease	0.00021	0.00119	CcSEcCtD
Melphalan—Decreased appetite—Prednisone—Crohn's disease	0.000207	0.00117	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000206	0.00351	CbGpPWpGaD
Melphalan—Fatigue—Prednisone—Crohn's disease	0.000205	0.00116	CcSEcCtD
Melphalan—Urticaria—Prednisone—Crohn's disease	0.000189	0.00107	CcSEcCtD
Melphalan—SLC22A3—Metabolism—PLA2G4F—Crohn's disease	0.000182	0.00311	CbGpPWpGaD
Melphalan—Hypersensitivity—Prednisone—Crohn's disease	0.000176	0.000992	CcSEcCtD
Melphalan—Asthenia—Prednisone—Crohn's disease	0.000171	0.000967	CcSEcCtD
Melphalan—Pruritus—Prednisone—Crohn's disease	0.000169	0.000953	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ALB—Crohn's disease	0.000168	0.00287	CbGpPWpGaD
Melphalan—Diarrhoea—Prednisone—Crohn's disease	0.000163	0.000922	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—JAK2—Crohn's disease	0.000157	0.00267	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MTMR3—Crohn's disease	0.000155	0.00264	CbGpPWpGaD
Melphalan—Vomiting—Prednisone—Crohn's disease	0.000152	0.000856	CcSEcCtD
Melphalan—Rash—Prednisone—Crohn's disease	0.00015	0.000849	CcSEcCtD
Melphalan—Dermatitis—Prednisone—Crohn's disease	0.00015	0.000849	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	0.000146	0.00249	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000146	0.00248	CbGpPWpGaD
Melphalan—Nausea—Prednisone—Crohn's disease	0.000142	0.0008	CcSEcCtD
Melphalan—SLC22A3—Metabolism—FADS1—Crohn's disease	0.000121	0.00206	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GPX4—Crohn's disease	0.000113	0.00193	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GCKR—Crohn's disease	0.000109	0.00186	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ALB—Crohn's disease	7.43e-05	0.00126	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALB—Crohn's disease	3.48e-05	0.000592	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—Crohn's disease	3.04e-05	0.000518	CbGpPWpGaD
